Annual CAPEX
$51.60 M
-$64.20 M-55.44%
31 December 2023
Summary:
Emergent BioSolutions annual capital expenditures is currently $51.60 million, with the most recent change of -$64.20 million (-55.44%) on 31 December 2023. During the last 3 years, it has fallen by -$90.30 million (-63.64%). EBS annual CAPEX is now -76.97% below its all-time high of $224.10 million, reached on 31 December 2021.EBS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$5.80 M
+$1.20 M+26.09%
30 September 2024
Summary:
Emergent BioSolutions quarterly capital expenditures is currently $5.80 million, with the most recent change of +$1.20 million (+26.09%) on 30 September 2024. Over the past year, it has dropped by -$6.80 million (-53.97%). EBS quarterly CAPEX is now -91.34% below its all-time high of $67.00 million, reached on 30 June 2021.EBS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$32.60 M
-$6.80 M-17.26%
30 September 2024
Summary:
Emergent BioSolutions TTM capital expenditures is currently $32.60 million, with the most recent change of -$6.80 million (-17.26%) on 30 September 2024. Over the past year, it has dropped by -$31.20 million (-48.90%). EBS TTM CAPEX is now -85.45% below its all-time high of $224.10 million, reached on 31 December 2021.EBS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -55.4% | -54.0% | -48.9% |
| 3 y3 years | -63.6% | -89.5% | -84.8% |
| 5 y5 years | -28.4% | -62.1% | -54.5% |
EBS CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -77.0% | at low | -89.5% | +26.1% | -85.5% | at low |
| 5 y | 5 years | -77.0% | at low | -91.3% | +26.1% | -85.5% | at low |
| alltime | all time | -77.0% | +690.0% | -91.3% | +61.1% | -85.5% | +97.7% |
Emergent BioSolutions CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.80 M(+26.1%) | $32.60 M(-17.3%) |
| June 2024 | - | $4.60 M(-57.4%) | $39.40 M(-16.7%) |
| Mar 2024 | - | $10.80 M(-5.3%) | $47.30 M(-8.3%) |
| Dec 2023 | $51.60 M(-55.4%) | $11.40 M(-9.5%) | $51.60 M(-19.1%) |
| Sept 2023 | - | $12.60 M(+0.8%) | $63.80 M(-19.3%) |
| June 2023 | - | $12.50 M(-17.2%) | $79.10 M(-19.9%) |
| Mar 2023 | - | $15.10 M(-36.0%) | $98.70 M(-14.8%) |
| Dec 2022 | $115.80 M(-48.3%) | $23.60 M(-15.4%) | $115.80 M(-16.1%) |
| Sept 2022 | - | $27.90 M(-13.1%) | $138.00 M(-16.5%) |
| June 2022 | - | $32.10 M(-0.3%) | $165.30 M(-17.4%) |
| Mar 2022 | - | $32.20 M(-29.7%) | $200.20 M(-10.7%) |
| Dec 2021 | $224.10 M(+57.9%) | $45.80 M(-17.0%) | $224.10 M(+4.1%) |
| Sept 2021 | - | $55.20 M(-17.6%) | $215.20 M(+4.6%) |
| June 2021 | - | $67.00 M(+19.4%) | $205.70 M(+18.4%) |
| Mar 2021 | - | $56.10 M(+52.0%) | $173.80 M(+22.5%) |
| Dec 2020 | $141.90 M(+63.3%) | $36.90 M(-19.3%) | $141.90 M(+0.6%) |
| Sept 2020 | - | $45.70 M(+30.2%) | $141.10 M(+27.5%) |
| June 2020 | - | $35.10 M(+45.0%) | $110.70 M(+23.4%) |
| Mar 2020 | - | $24.20 M(-33.0%) | $89.70 M(+3.2%) |
| Dec 2019 | $86.90 M(+20.5%) | $36.10 M(+135.9%) | $86.90 M(+21.4%) |
| Sept 2019 | - | $15.30 M(+8.5%) | $71.60 M(-13.1%) |
| June 2019 | - | $14.10 M(-34.1%) | $82.40 M(+0.6%) |
| Mar 2019 | - | $21.40 M(+2.9%) | $81.90 M(+13.6%) |
| Dec 2018 | $72.10 M(+31.6%) | $20.80 M(-20.3%) | $72.10 M(+13.2%) |
| Sept 2018 | - | $26.10 M(+91.9%) | $63.72 M(+26.4%) |
| June 2018 | - | $13.60 M(+17.2%) | $50.40 M(+9.3%) |
| Mar 2018 | - | $11.60 M(-6.6%) | $46.10 M(-15.9%) |
| Dec 2017 | $54.80 M(-28.1%) | $12.42 M(-2.8%) | $54.80 M(-12.1%) |
| Sept 2017 | - | $12.78 M(+37.4%) | $62.34 M(-6.3%) |
| June 2017 | - | $9.30 M(-54.2%) | $66.56 M(-15.0%) |
| Mar 2017 | - | $20.30 M(+1.7%) | $78.29 M(+2.7%) |
| Dec 2016 | $76.20 M(+70.0%) | $19.96 M(+17.4%) | $76.20 M(+13.0%) |
| Sept 2016 | - | $17.00 M(-19.2%) | $67.42 M(+4.7%) |
| June 2016 | - | $21.03 M(+15.5%) | $64.38 M(+19.3%) |
| Mar 2016 | - | $18.21 M(+62.9%) | $53.94 M(+20.4%) |
| Dec 2015 | $44.81 M | $11.18 M(-19.8%) | $44.81 M(-9.8%) |
| Sept 2015 | - | $13.95 M(+31.6%) | $49.68 M(+21.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $10.60 M(+16.7%) | $40.95 M(+16.5%) |
| Mar 2015 | - | $9.08 M(-43.4%) | $35.16 M(+14.6%) |
| Dec 2014 | $30.67 M(-27.0%) | $16.05 M(+207.5%) | $30.67 M(+38.0%) |
| Sept 2014 | - | $5.22 M(+8.5%) | $22.22 M(-40.4%) |
| June 2014 | - | $4.81 M(+4.8%) | $37.30 M(-4.2%) |
| Mar 2014 | - | $4.59 M(-39.6%) | $38.93 M(-7.4%) |
| Dec 2013 | $42.02 M(-22.0%) | $7.60 M(-62.6%) | $42.02 M(-11.2%) |
| Sept 2013 | - | $20.30 M(+215.0%) | $47.32 M(+27.7%) |
| June 2013 | - | $6.44 M(-16.1%) | $37.05 M(-5.5%) |
| Mar 2013 | - | $7.68 M(-40.5%) | $39.20 M(-27.2%) |
| Dec 2012 | $53.84 M(-0.3%) | $12.90 M(+28.7%) | $53.84 M(-11.5%) |
| Sept 2012 | - | $10.02 M(+16.6%) | $60.82 M(-10.8%) |
| June 2012 | - | $8.59 M(-61.5%) | $68.15 M(+0.3%) |
| Mar 2012 | - | $22.33 M(+12.4%) | $67.92 M(+25.7%) |
| Dec 2011 | $54.03 M(+144.5%) | $19.87 M(+14.5%) | $54.03 M(+28.0%) |
| Sept 2011 | - | $17.36 M(+107.6%) | $42.21 M(+39.5%) |
| June 2011 | - | $8.36 M(-0.8%) | $30.27 M(+18.7%) |
| Mar 2011 | - | $8.43 M(+4.6%) | $25.50 M(+15.4%) |
| Dec 2010 | $22.10 M(-33.6%) | $8.06 M(+48.9%) | $22.10 M(-32.9%) |
| Sept 2010 | - | $5.41 M(+50.3%) | $32.95 M(+0.4%) |
| June 2010 | - | $3.60 M(-28.4%) | $32.82 M(-2.2%) |
| Mar 2010 | - | $5.03 M(-73.4%) | $33.56 M(+0.8%) |
| Dec 2009 | $33.29 M(+59.9%) | $18.91 M(+258.0%) | $33.29 M(+77.8%) |
| Sept 2009 | - | $5.28 M(+21.7%) | $18.73 M(+7.8%) |
| June 2009 | - | $4.34 M(-8.7%) | $17.36 M(-6.8%) |
| Mar 2009 | - | $4.75 M(+9.3%) | $18.64 M(-10.5%) |
| Dec 2008 | $20.81 M(-52.7%) | $4.35 M(+10.9%) | $20.81 M(-14.1%) |
| Sept 2008 | - | $3.92 M(-30.1%) | $24.24 M(-16.9%) |
| June 2008 | - | $5.61 M(-19.0%) | $29.17 M(-15.2%) |
| Mar 2008 | - | $6.93 M(-10.8%) | $34.41 M(-21.7%) |
| Dec 2007 | $43.97 M(+6.6%) | $7.77 M(-12.2%) | $43.97 M(+21.5%) |
| Sept 2007 | - | $8.85 M(-18.4%) | $36.20 M(+32.4%) |
| June 2007 | - | $10.85 M(-34.2%) | $27.34 M(+65.8%) |
| Mar 2007 | - | $16.49 M | $16.49 M |
| Dec 2006 | $41.23 M(+531.2%) | - | - |
| Dec 2005 | $6.53 M(-61.7%) | - | - |
| Dec 2004 | $17.07 M | - | - |
FAQ
- What is Emergent BioSolutions annual capital expenditures?
- What is the all time high annual CAPEX for Emergent BioSolutions?
- What is Emergent BioSolutions annual CAPEX year-on-year change?
- What is Emergent BioSolutions quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly CAPEX year-on-year change?
- What is Emergent BioSolutions TTM capital expenditures?
- What is the all time high TTM CAPEX for Emergent BioSolutions?
- What is Emergent BioSolutions TTM CAPEX year-on-year change?
What is Emergent BioSolutions annual capital expenditures?
The current annual CAPEX of EBS is $51.60 M
What is the all time high annual CAPEX for Emergent BioSolutions?
Emergent BioSolutions all-time high annual capital expenditures is $224.10 M
What is Emergent BioSolutions annual CAPEX year-on-year change?
Over the past year, EBS annual capital expenditures has changed by -$64.20 M (-55.44%)
What is Emergent BioSolutions quarterly capital expenditures?
The current quarterly CAPEX of EBS is $5.80 M
What is the all time high quarterly CAPEX for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly capital expenditures is $67.00 M
What is Emergent BioSolutions quarterly CAPEX year-on-year change?
Over the past year, EBS quarterly capital expenditures has changed by -$6.80 M (-53.97%)
What is Emergent BioSolutions TTM capital expenditures?
The current TTM CAPEX of EBS is $32.60 M
What is the all time high TTM CAPEX for Emergent BioSolutions?
Emergent BioSolutions all-time high TTM capital expenditures is $224.10 M
What is Emergent BioSolutions TTM CAPEX year-on-year change?
Over the past year, EBS TTM capital expenditures has changed by -$31.20 M (-48.90%)